help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asakura, S.
Right arrow Articles by Limper, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asakura, S.
Right arrow Articles by Limper, A. H.

Am. J. Respir. Crit. Care Med., Vol 154, No. 5, 11 1996, 1525-1530.

Tissue localization of transforming growth factor-beta1 in pulmonary eosinophilic granuloma

S Asakura, TV Colby and AH Limper
The Thoracic Diseases Research Unit, Mayo Clinic, Rochester, Minnesota, USA.

Pulmonary eosinophilic granuloma is characterized by infiltration of the lungs with fibronodular lesions containing specialized Langerhans' cells. In some patients, progressive pulmonary fibrosis leads to significant respiratory impairment. Transforming growth factor-beta1 (TGF-beta1) promotes fibrosis by enhancing the synthesis of extracellular matrix components. The role of TGF-beta1 in promoting fibrosis in the setting of pulmonary eosinophilic granuloma is currently unknown. We used immunohistochemistry to evaluate the extent and distribution of TGF-beta1 and the extracellular matrix components type I collagen and decorin, a TGF-beta1-binding proteoglycan. Lung biopsies from 11 patients with pulmonary eosinophilic granuloma were evaluated. In biopsies with active inflammatory lesions containing Langerhans' cells, hyperplastic type 2 pneumocytes and alveolar macrophages within and surrounding the fibronodular lesions contained abundant TGF-beta1. Langerhans' cells were consistently devoid of immunoreactive TGF-beta1. Active inflammatory lesions also exhibited staining for decorin, in a loosely organized distribution. Advanced fibrotic lesions of eosinophilic granuloma, containing minimal inflammatory cells and few or no Langerhans' cells, exhibited weak or absent staining for TGF-beta1 within either hyperplastic type 2 pneumocytes or alveolar macrophages. The fibroconnective tissues of these advanced fibrotic lesions consistently revealed dense staining for decorin. Through their actions on extracellular matrix protein accumulation, TGF-beta1 and the TGF-beta1-binding proteoglycan decorin may modulate fibrotic repair accompanying pulmonary eosinophilic granuloma.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
A. Tazi
Adult pulmonary Langerhans' cell histiocytosis.
Eur. Respir. J., June 1, 2006; 27(6): 1272 - 1285.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Vermaelen and R. Pauwels
Pulmonary Dendritic Cells
Am. J. Respir. Crit. Care Med., September 1, 2005; 172(5): 530 - 551.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
U. Bartram and C. P. Speer
The Role of Transforming Growth Factor {beta} in Lung Development and Disease
Chest, February 1, 2004; 125(2): 754 - 765.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Nadesalingam, A. L. Bernal, A. W. Dodds, A. C. Willis, D. J. Mahoney, A. J. Day, K. B. M. Reid, and N. Palaniyar
Identification and Characterization of a Novel Interaction between Pulmonary Surfactant Protein D and Decorin
J. Biol. Chem., July 3, 2003; 278(28): 25678 - 25687.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. M. Sundar, M. V. Gosselin, H. L. Chung, and B. C. Cahill
Pulmonary Langerhans Cell Histiocytosis: Emerging Concepts in Pathobiology, Radiology, and Clinical Evolution of Disease
Chest, May 1, 2003; 123(5): 1673 - 1683.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. L. Myers and M.-C. Aubry
Pulmonary Langerhans Cell Histiocytosis: What Was the Question?
Am. J. Respir. Crit. Care Med., December 1, 2002; 166(11): 1419 - 1421.
[Full Text] [PDF]

Home page
 NEJMHome page
J. Rajagopol and E. J. Mark
Case 32-2002 - A 58-Year-Old Man with Interstitial Pulmonary Disease
N. Engl. J. Med., October 17, 2002; 347(16): 1262 - 1268.
[Full Text] [PDF]

Home page
 BloodHome page
J. Xaus, M. Comalada, M. Cardo, A. F. Valledor, and A. Celada
Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27Kip1 and p21Waf1
Blood, October 1, 2001; 98(7): 2124 - 2133.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. Vassallo, J. H. Ryu, T. V. Colby, T. Hartman, and A. H. Limper
Pulmonary Langerhans'-Cell Histiocytosis
N. Engl. J. Med., June 29, 2000; 342(26): 1969 - 1978.
[Full Text] [PDF]

Home page
 ThoraxHome page
A. Tazi, P. Soler, and A. J Hance
Rare diseases bullet 9: Adult pulmonary Langerhans' cell histiocytosis
Thorax, May 1, 2000; 55(5): 405 - 416.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. FARTOUKH, M. HUMBERT, F. CAPRON, S. MAÎTRE, F. PARENT, C. LE GALL, O. SITBON, P. HERVÉ, P. DUROUX, and G. SIMONNEAU
Severe Pulmonary Hypertension in Histiocytosis X
Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 216 - 223.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1996 American Thoracic Society 		  Solid Organ Transplant for the Intensivist 2008